Erythema Nodosum Leprosum
📧 Sign up to get email alerts when something new happens for Erythema Nodosum Leprosum.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-12-04FDA Approved: THALOMID — Supplemental Application (Celgene Corporation)
FDA approved a supplemental application for Thalomid (thalidomide) submitted by Celgene Corporation.
-
FDA approval · 2017-11-30FDA Approved: THALOMID — Supplemental Application (Celgene Corporation)
FDA approved a supplemental application for THALOMID (thalidomide) submitted by Celgene Corporation.
-
FDA approval · 2014-09-12FDA Approved: THALOMID — Supplemental Application (Celgene Corporation)
FDA approved a supplemental application for THALOMID (thalidomide) submitted by Celgene Corporation, resulting in an expanded indication.